ChronoScale Holdings Corporation (CHRN)
| Market Cap | 2.95B +28,500.8% |
| Revenue (ttm) | 71.60M -15.1% |
| Net Income | -50.43M |
| EPS | -0.36 |
| Shares Out | 145.64M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 138,509 |
| Open | 19.60 |
| Previous Close | 20.08 |
| Day's Range | 19.51 - 20.59 |
| 52-Week Range | 3.47 - 30.00 |
| Beta | 0.99 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 19, 2026 |
About CHRN
ChronoScale Holdings Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads in the United States. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. It also provides graphics processing units; computing solutions; AI; machine learning; and high-performance computing solutions. It serves artificial intelligence and machine learning developers. The company was formerly known as Chrono... [Read more]
Financial Performance
Financial StatementsNews
ChronoScale Stock (CHRN) Soars 11% on a 50-Megawatt AI Data Center Deal with Microsoft (MSFT)
ChronoScale stock was up on Thursday after the company announced a deal with Microsoft to develop a new AI data center.
ChronoScale announces plans with Microsoft for 50-megawatt AI compute deployment
ChronoScale (CHRN) announced plans with Microsoft (MSFT) for a 50-megawatt AI compute deployment in North America. The deployment will feature Nvidia (NVDA) GB300 NVL72 systems and advanced liquid-coo...
ChronoScale Announces AI Infrastructure Partnership with Microsoft for 50 MW AI Compute Deployment in North America
MENLO PARK, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN), (“ChronoScale” or the “Company”), an accelerated compute platform purpose-built to support demanding artif...
Nutanix, ChronoScale enter strategic partnership
Nutanix (NTNX) and ChronoScale (CHRN) announced a strategic partnership to jointly deliver enterprise-ready AI infrastructure and help accelerate adoption of AI services across global markets. The par...
Nutanix and ChronoScale Announce Strategic Partnership to Accelerate Enterprise AI Adoption
Nutanix and ChronoScale plan to integrate their platforms so enterprises can extend into ChronoScale GPU-as-a-Service, pre-paid inference tokens through ChronoScale Token Factory, and a locally-deploy...
ChronoScale falls -10.7%
ChronoScale (CHRN) is down -10.7%, or -$3.08 to $25.81.
ChronoScale falls -19.5%
ChronoScale (CHRN) is down -19.5%, or -$5.78 to $23.85.
ChronoScale falls -18.5%
ChronoScale (CHRN) is down -18.5%, or -$5.48 to $24.15.
ChronoScale Holdings Registration statement: Registration filing
ChronoScale Holdings filed a registration statement on July 10, 2026, providing details about a securities offering with the SEC.
ChronoScale falls -17.9%
ChronoScale (CHRN) is down -17.9%, or -$3.97 to $18.25.
ChronoScale files to sell 1.1M shares of common stock for holders
17:26 EDT ChronoScale (CHRN) files to sell 1.1M shares of common stock for holders
ChronoScale Holdings Registration statement: Registration filing
ChronoScale Holdings filed a registration statement on June 30, 2026, providing details about a securities offering with the SEC.
ChronoScale Stock (CHRN) Surges on Rising Investor Interest In AI
ChronoScale stock was up on Thursday as investors take interest in AI-related companies.
ChronoScale appoints Raj Jegannathan as CTO, Lawrence Lam as CPO
ChronoScale (CHRN) announced the appointments of Raj Jegannathan as chief technology officer, or CTO, and Lawrence Lam as chief product officer, or CPO. Jegannathan joins ChronoScale as CTO after an…
ChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure Strategy
DALLAS, June 04, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN) (“ChronoScale” or the “Company”), an accelerated compute platform purpose-built to support demanding artificial intelli...
ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth
DALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced t...
Ekso Bionics Prices $5.852 million Private Placement
SAN RAFAEL, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced th...
Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale
DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artific...
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System
SAN RAFAEL, Calif. and TNUVOT, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for ...
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
SAN RAFAEL, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced th...